192 related articles for article (PubMed ID: 34279996)
1. Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic
Guertin J; Kaiser Y; Manikpurage H; Perrot N; Bourgeois R; Couture C; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Clavel MA; Thériault S; Boekholdt SM; Arsenault BJ
Circ Genom Precis Med; 2021 Aug; 14(4):e003271. PubMed ID: 34279996
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.
Perrot N; Thériault S; Dina C; Chen HY; Boekholdt SM; Rigade S; Després AA; Poulin A; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Khaw KT; Wareham NJ; Dweck MR; Mathieu P; Pibarot P; Schott JJ; Thanassoulis G; Clavel MA; Bossé Y; Arsenault BJ
JAMA Cardiol; 2019 Jul; 4(7):620-627. PubMed ID: 31141105
[TBL] [Abstract][Full Text] [Related]
3. Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis.
Arsenault BJ; Pelletier W; Kaiser Y; Perrot N; Couture C; Khaw KT; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Thériault S; Boekholdt SM
JAMA Netw Open; 2020 Feb; 3(2):e200129. PubMed ID: 32108890
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
[TBL] [Abstract][Full Text] [Related]
5. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Burgess S; Ference BA; Staley JR; Freitag DF; Mason AM; Nielsen SF; Willeit P; Young R; Surendran P; Karthikeyan S; Bolton TR; Peters JE; Kamstrup PR; Tybjærg-Hansen A; Benn M; Langsted A; Schnohr P; Vedel-Krogh S; Kobylecki CJ; Ford I; Packard C; Trompet S; Jukema JW; Sattar N; Di Angelantonio E; Saleheen D; Howson JMM; Nordestgaard BG; Butterworth AS; Danesh J;
JAMA Cardiol; 2018 Jul; 3(7):619-627. PubMed ID: 29926099
[TBL] [Abstract][Full Text] [Related]
6. Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression.
Girard A; Gaillard E; Puri R; Capoulade R; Chan KL; Paulin A; Manikpurage HD; Dumesnil J; Tam JW; Teo KK; Couture C; Wareham NJ; Clavel MA; Stroes ESG; Mathieu P; Thériault S; Tsimikas S; Pibarot P; Boekholdt SM; Arsenault BJ
Eur Heart J Open; 2023 Mar; 3(2):oead032. PubMed ID: 37077580
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
[TBL] [Abstract][Full Text] [Related]
8. Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.
Satterfield BA; Dikilitas O; Safarova MS; Clarke SL; Tcheandjieu C; Zhu X; Bastarache L; Larson EB; Justice AE; Shang N; Rosenthal EA; Shah AS; Namjou-Khales B; Urbina EM; Wei WQ; Feng Q; Jarvik GP; Hebbring SJ; de Andrade M; Manolio TA; Assimes TL; Kullo IJ
Circ Genom Precis Med; 2021 Aug; 14(4):e003354. PubMed ID: 34282949
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
Coassin S; Chemello K; Khantalin I; Forer L; Döttelmayer P; Schönherr S; Grüneis R; Chong-Hong-Fong C; Nativel B; Ramin-Mangata S; Gallo A; Roche M; Muelegger B; Gieger C; Peters A; Zschocke J; Marimoutou C; Meilhac O; Lamina C; Kronenberg F; Blanchard V; Lambert G
Circ Genom Precis Med; 2022 Apr; 15(2):e003489. PubMed ID: 35133173
[TBL] [Abstract][Full Text] [Related]
10. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
Wang L; Chen J; Zeng Y; Wei J; Jing J; Li G; Su L; Tang X; Wu T; Zhou L
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1989-96. PubMed ID: 27417586
[TBL] [Abstract][Full Text] [Related]
11. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
12. Plasma Lipoprotein(a) measured in routine clinical care and the association with incident calcified aortic valve stenosis during a 14-year observational period.
Wodaje T; Littmann K; Häbel H; Bottai M; Bäck M; Parini P; Brinck J
Atherosclerosis; 2022 May; 349():175-182. PubMed ID: 35277251
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations with valvular calcification and aortic stenosis.
Thanassoulis G; Campbell CY; Owens DS; Smith JG; Smith AV; Peloso GM; Kerr KF; Pechlivanis S; Budoff MJ; Harris TB; Malhotra R; O'Brien KD; Kamstrup PR; Nordestgaard BG; Tybjaerg-Hansen A; Allison MA; Aspelund T; Criqui MH; Heckbert SR; Hwang SJ; Liu Y; Sjogren M; van der Pals J; Kälsch H; Mühleisen TW; Nöthen MM; Cupples LA; Caslake M; Di Angelantonio E; Danesh J; Rotter JI; Sigurdsson S; Wong Q; Erbel R; Kathiresan S; Melander O; Gudnason V; O'Donnell CJ; Post WS;
N Engl J Med; 2013 Feb; 368(6):503-12. PubMed ID: 23388002
[TBL] [Abstract][Full Text] [Related]
14. Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.
Allara E; Morani G; Carter P; Gkatzionis A; Zuber V; Foley CN; Rees JMB; Mason AM; Bell S; Gill D; Lindström S; Butterworth AS; Di Angelantonio E; Peters J; Burgess S;
Circ Genom Precis Med; 2019 Dec; 12(12):e002711. PubMed ID: 31756303
[TBL] [Abstract][Full Text] [Related]
15. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
Grüneis R; Lamina C; Di Maio S; Schönherr S; Zoescher P; Forer L; Streiter G; Peters A; Gieger C; Köttgen A; Kronenberg F; Coassin S
Atherosclerosis; 2022 May; 349():151-159. PubMed ID: 35534298
[TBL] [Abstract][Full Text] [Related]
16. Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
Mohammadi-Shemirani P; Chong M; Narula S; Perrot N; Conen D; Roberts JD; Thériault S; Bossé Y; Lanktree MB; Pigeyre M; Paré G
J Am Coll Cardiol; 2022 Apr; 79(16):1579-1590. PubMed ID: 35450575
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.
Emdin CA; Khera AV; Natarajan P; Klarin D; Won HH; Peloso GM; Stitziel NO; Nomura A; Zekavat SM; Bick AG; Gupta N; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Willer C; Abecasis GR; Felix JF; Vasan RS; Lander E; Rader DJ; Danesh J; Ardissino D; Gabriel S; Saleheen D; Kathiresan S; ;
J Am Coll Cardiol; 2016 Dec; 68(25):2761-2772. PubMed ID: 28007139
[TBL] [Abstract][Full Text] [Related]
18. Association between lipoprotein(a), LPA genetic risk score, aortic valve disease, and subsequent major adverse cardiovascular events.
Moore MK; Jones GT; McCormick S; Williams MJA; Coffey S
Eur J Prev Cardiol; 2024 Apr; ():. PubMed ID: 38593219
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
[TBL] [Abstract][Full Text] [Related]
20. New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular Disease.
Nestel P; Loh WJ; Ward NC; Watts GF
J Clin Endocrinol Metab; 2022 Nov; 107(11):e4281-e4294. PubMed ID: 36108076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
